Engineered T Cells Secreting Anti-BCMA T Cell Engagers Control Multiple Myeloma and Promote Immune Memory In Vivo

Researchers undertook a comprehensive preclinical study comparing the therapeutic potential of T cells either expressing second-generation anti-B cell maturation antigen (BCMA) CARs or secreting BCMAxCD3 T cell engagers in a T cell–limiting experimental setting.